Neogen (NASDAQ:NEOG - Get Free Report) is projected to post its Q1 2026 results before the market opens on Thursday, October 9th. Analysts expect Neogen to post earnings of $0.05 per share and revenue of $203.9330 million for the quarter. Parties may review the information on the company's upcoming Q1 2026 earningreport for the latest details on the call scheduled for Thursday, October 9, 2025 at 8:00 AM ET.
Neogen Price Performance
Shares of NEOG opened at $5.80 on Thursday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.22 and a current ratio of 3.32. The company has a 50 day moving average price of $5.42 and a 200-day moving average price of $5.79. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $16.79. The stock has a market capitalization of $1.26 billion, a PE ratio of -1.15 and a beta of 1.90.
Wall Street Analyst Weigh In
A number of research firms have weighed in on NEOG. CJS Securities assumed coverage on Neogen in a report on Monday. They set a "market perform" rating and a $10.00 target price for the company. Zacks Research upgraded Neogen from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. William Blair lowered Neogen from an "outperform" rating to a "market perform" rating in a research note on Tuesday, July 29th. Finally, Guggenheim reduced their target price on shares of Neogen from $13.00 to $10.00 and set a "buy" rating for the company in a report on Monday, June 30th. One research analyst has rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $8.33.
Read Our Latest Stock Report on Neogen
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp lifted its stake in shares of Neogen by 5,687.3% during the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company's stock worth $290,000 after buying an additional 32,816 shares during the period. Tidal Investments LLC purchased a new position in Neogen in the 2nd quarter worth $263,000. Corient Private Wealth LLC raised its stake in Neogen by 129.8% in the 2nd quarter. Corient Private Wealth LLC now owns 47,177 shares of the company's stock worth $226,000 after acquiring an additional 26,643 shares during the last quarter. XTX Topco Ltd acquired a new stake in Neogen during the 2nd quarter worth about $204,000. Finally, Vident Advisory LLC purchased a new stake in Neogen during the 2nd quarter valued at about $190,000. Institutional investors and hedge funds own 96.73% of the company's stock.
About Neogen
(
Get Free Report)
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Neogen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list.
While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.